Alexion Pharmaceuticals, Inc. (ALXN): Price and Financial Metrics
ALXN Price/Volume Stats
| Current price | $182.50 | 52-week high | $187.45 |
| Prev. close | $179.45 | 52-week low | $99.91 |
| Day low | $180.13 | Volume | 90,506,096 |
| Day high | $182.67 | Avg. volume | 3,309,941 |
| 50-day MA | $179.55 | Dividend yield | N/A |
| 200-day MA | $153.74 | Market Cap | 40.34B |
ALXN Stock Price Chart Interactive Chart >
Alexion Pharmaceuticals, Inc. (ALXN) Company Bio
Alexion Pharmaceuticals a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company was founded in 1992 and is based in Cheshire, Connecticut.
Latest ALXN News From Around the Web
Below are the latest news stories about Alexion Pharmaceuticals Inc that investors may wish to consider to help them evaluate ALXN as an investment opportunity.
AstraZeneca's Acquisition of Alexion Is Nearly a Done Deal, But Is It a Good Deal?AstraZeneca (NASDAQ: AZN) hopes to soon close its planned acquisition of Alexion Pharmaceuticals (NASDAQ: ALXN). In this Motley Fool Live video recorded on July 7, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not the Alexion acquisition is a good deal for AstraZeneca. Keith Speights: AstraZeneca has experienced multiple problems with the launch of its COVID-19 vaccine and we're not going to get into all of those problems but there's more news non-COVID related for AstraZeneca now. |
With the Alexion Acquisition Set to Close This Quarter, Is AstraZeneca a Buy?With UK approval, the $39 billion deal for rare disorders biotech company Alexion Pharmaceuticals is set to close on July 21. |
MRNA Stock: 10 Things to Know About Moderna as It Gets Ready to Join the S&P 500Moderna (MRNA) stock is on the rise Friday as the company prepares to join the S&P 500 next week replacing Alexion Pharmaceuticals (ALXN). |
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.What did the stock market do today? |
When Will Moderna Be Added to the S&P 500?Moderna is joining the S&P 500 on July 21, replacing Alexion Pharmaceuticals. |
ALXN Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 8.35% |
| 5-year | 41.52% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | 44.47% |
| 2019 | 11.08% |
Continue Researching ALXN
Want to see what other sources are saying about Alexion Pharmaceuticals Inc's financials and stock price? Try the links below:Alexion Pharmaceuticals Inc (ALXN) Stock Price | Nasdaq
Alexion Pharmaceuticals Inc (ALXN) Stock Quote, History and News - Yahoo Finance
Alexion Pharmaceuticals Inc (ALXN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...